פוטאקטזול 1 מ"ג

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

TOPOTECAN HYDROCHLORIDE 1 MG

MAH:

DEVRIES & CO. LTD

ATC_code:

L01XX17

pharmaceutical_form:

POWDER FOR CONCENTRATE FOR SOUTION FOR INFUSION

administration_route:

I.V

manufactured_by:

ACTAVIS GROUP PTC ehf, ICELAND

therapeutic_group:

TOPOTECAN

therapeutic_indication:

Treatment of metastatic carcinoma of the ovary after failure of initial or subsequent therapy. Treatment of small cell lung cancer sensitive disease after failure of first line chemotherapy. Topotecan in combination with cisplatin is indicated for the treatment of Stage IV-B recurrent or persistent carcinoma of the cervix which is not amenable to curative treatment with surgery and/or radiation therapy.

authorization_date:

2012-12-01